Hematopoietic Stem Cell TransplantationStem CellsStem Cell TransplantationTransplantation, HomologousTransplantation, AutologousHematopoietic Stem CellsTransplantationGraft vs Host DiseaseHematologic NeoplasmsEmbryonic Stem CellsAdult Stem CellsTransplantation ConditioningTissue DonorsImmunocompromised HostBone Marrow TransplantationCytomegalovirus InfectionsPeripheral Blood Stem Cell TransplantationGraft SurvivalPluripotent Stem CellsTreatment OutcomeMesenchymal Stem Cell TransplantationImmunosuppressive AgentsOpportunistic InfectionsKidney TransplantationStem Cell NicheCell DifferentiationHistocompatibilityMycosesHistocompatibility TestingNeural Stem CellsAspergillosisRetrospective StudiesInduced Pluripotent Stem CellsRoseolovirus InfectionsTime FactorsHematopoietic Stem Cell MobilizationGraft RejectionTransplantsMesenchymal Stromal CellsMultipotent Stem CellsCytomegalovirusStem Cell FactorTransplantation ChimeraRecurrenceBlood Transfusion, AutologousCells, CulturedWhole-Body IrradiationMultiple MyelomaAntifungal AgentsHematologic DiseasesAntiviral AgentsBusulfanImmunosuppressionLeukemiaAntigens, CD34Flow CytometryHepatic Veno-Occlusive DiseaseCyclosporineCord Blood Stem Cell TransplantationCell LineageHerpesvirus 6, HumanFatal OutcomeGanciclovirCombined Modality TherapyHeart TransplantationBK VirusAcute DiseaseZygomycosisStem Cell ResearchCell ProliferationSurvival RateSalvage TherapyBone Marrow CellsSurvival AnalysisPolyomavirus InfectionsPostoperative ComplicationsAnemia, AplasticPlant StemsFetal Stem CellsT-LymphocytesRisk FactorsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCell SeparationLymphoproliferative DisordersFollow-Up StudiesMice, Inbred C57BLTriazolesMyeloablative AgonistsPrecursor Cell Lymphoblastic Leukemia-LymphomaAntineoplastic Combined Chemotherapy ProtocolsChimerismVirus ActivationPolymerase Chain ReactionLeukemia, Myeloid, AcuteProspective StudiesNeoplasmsNeutropeniaViral LoadGranulocyte Colony-Stimulating FactorAdenoviridae Infections